CompletedNot Applicable

Evaluation of the Lung Clearance Index

France53 participantsStarted 2014-04

Plain-language summary

The purpose of this study is to determine the efficacy of a non invasive method of detecting the pulmonary disease in order to initiate treatment against cystic fibrosis as soon as possible. Moreover this screening procedure permits to note the improvement following the treatment and to choose the optimal treatment in term of efficacy.

Who can participate

Age range3 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with typical cystic fibrosis (sweat chloride level \>60 mEq/l) followed in reference centre participating to the study * From 3 to 6 years old * Children with a planned annual assessment that required thoracic computed tomography and lung function test * Children with informed and non opposed parents Exclusion Criteria: * Children with atypical cystic fibrosis * Children with bronchial exacerbation dating less than 2 weeks * Children with severe associated disease

What they're measuring

measure of nitrogen washout and Brody 2 score

Timeframe: Month 0

Trial details

NCT IDNCT02342951

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04

View on ClinicalTrials.gov More Cystic Fibrosis trials